历史沿革 History
建于1918年，由伍连德博士创办，最初名为“北京中央医院”，被称为中国人自行筹资创办的第一所现代综合医院之一。
Established in 1918 by Dr. Lien-teh Wu as the "Central Hospital," it is described as one of the first modern comprehensive hospitals funded and built by Chinese people.
医院级别与规模 Grade & Scale
- 医院级别：三级甲等综合医院。
Grade: Tertiary Grade-A Comprehensive Hospital. - 床位数：多院区（西直门、清河、通州院区）编制/开放床位约2,300-2,500张。
Beds: Approximately 2,300–2,500 beds across the Xizhimen, Qinghe, and Tongzhou campuses. - 诊疗与手术规模（年）：年门急诊量约280万-320万人次，年出院人数约8万-10万人次，年手术量约4万-5万例。
Annual Volume: ~2.8–3.2 million outpatient/emergency visits, ~80,000–100,000 inpatient admissions, and 40,000–50,000+ surgeries annually.
检验与硬件设备 Equipment & Diagnostics
拥有造血干细胞移植无菌层流病房集群、单细胞测序平台、高档数字减影血管造影（DSA）及术中导航系统。
Houses a hematopoietic stem cell transplantation (HSCT) sterile laminar airflow ward cluster, single-cell sequencing platforms, and advanced digital subtraction angiography (DSA) suites.
特色专科 Key Specialties
血液病科（造血干细胞移植/白血病）、骨关节科（关节置换）、胸外科（胸腔镜微创）、创伤骨科。
Hematology (HSCT/Leukemia), Orthopedic Joint Surgery, Thoracic Surgery (VATS), and Trauma Orthopedics.
学术论文与引用 Publications & Citations
血液病团队（陆道培院士奠基）在Blood、Journal of Hematology & Oncology发表白血病“北京方案”系列文章，被写入国际指南。
The hematology team (founded on the work of Acad. Daopei Lu) is credited with the "Beijing Protocol" for haploidentical transplantation, published in Blood and Journal of Hematology & Oncology and cited in international guidelines.
国际合作 Global Partnerships
是全球造血干细胞移植（EBMT/CIBMTR）合作单位之一，与美国MD Anderson、欧洲骨髓移植学会有合作。
A collaborating center with the European Society for Blood and Marrow Transplantation (EBMT) and CIBMTR, partnering with MD Anderson Cancer Center